Volgen
Carmen Gasca-Salas
Carmen Gasca-Salas
CINAC-HM Puerta del Sur. CEU San Pablo University. Madrid
Geverifieerd e-mailadres voor hmhospitales.com
Titel
Geciteerd door
Geciteerd door
Jaar
Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study
R Martínez-Fernández, R Rodríguez-Rojas, M Del Álamo, ...
The Lancet Neurology 17 (1), 54-63, 2018
2142018
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
C Gasca-Salas, B Fernández-Rodríguez, JA Pineda-Pardo, ...
Nature communications 12 (1), 779, 2021
1642021
Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process
R Gonzalez-Redondo, D García-García, P Clavero, C Gasca-Salas, ...
Brain 137 (8), 2356-2367, 2014
1562014
Actualización en la enfermedad de Parkinson
R Martínez-Fernández, C Gasca-Salas, Á Sánchez-Ferro, JÁ Obeso
Revista Médica Clínica Las Condes 27 (3), 363-379, 2016
1552016
Randomized trial of focused ultrasound subthalamotomy for Parkinson’s disease
R Martínez-Fernández, JU Máñez-Miró, R Rodríguez-Rojas, M Del Álamo, ...
New England Journal of Medicine 383 (26), 2501-2513, 2020
1382020
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease
D Garcia-Garcia, P Clavero, C Gasca Salas, I Lamet, J Arbizu, ...
European journal of nuclear medicine and molecular imaging 39, 1767-1777, 2012
1242012
The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: a cross-sectional multicenter study
L Vela, JCM Castrillo, PG Ruiz, C Gasca-Salas, YM Macías, ...
Journal of the neurological sciences 368, 150-154, 2016
1012016
Parkinson's disease mild cognitive impairment: application and validation of the criteria
GJ Geurtsen, J Hoogland, JG Goldman, BA Schmand, AI Tröster, DJ Burn, ...
Journal of Parkinson's disease 4 (2), 131-137, 2014
812014
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment
C Gasca‐Salas, P Clavero, D García‐García, JA Obeso, ...
Human brain mapping 37 (3), 968-977, 2016
612016
Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease
C Gasca-Salas, A Estanga, P Clavero, I Aguilar-Palacio, ...
Journal of Parkinson's disease 4 (4), 677-686, 2014
552014
The long-term outcome of orthostatic tremor
C Ganos, L Maugest, E Apartis, C Gasca-Salas, MT Cáceres-Redondo, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 167-172, 2016
532016
A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data
G Pagano, FG Boess, KI Taylor, B Ricci, W Poewe, M Britschgi, ...
Frontiers in neurology 12, 705407, 2021
482021
Cortical disinhibition in Parkinson’s disease
C Ammann, M Dileone, C Pagge, V Catanzaro, D Mata-Marín, ...
Brain 143 (11), 3408-3421, 2020
472020
Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography
WM Arif, PH Elsinga, C Gasca-Salas, M Versluis, R Martínez-Fernández, ...
Journal of controlled release 324, 303-316, 2020
472020
Cognitive and psychiatric symptoms in genetically determined Parkinson’s disease: a systematic review
R Piredda, P Desmarais, M Masellis, C Gasca‐Salas
European journal of neurology 27 (2), 229-234, 2020
422020
Neurologic diagnostic criteria for functional neurologic disorders
C Gasca-Salas, AE Lang
Handbook of clinical neurology 139, 193-212, 2016
422016
Striatal blood–brain barrier opening in Parkinson's disease dementia: a pilot exploratory study
JA Pineda‐Pardo, C Gasca‐Salas, B Fernández‐Rodríguez, ...
Movement Disorders 37 (10), 2057-2065, 2022
282022
Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia
C Gasca-Salas, D García-Lorenzo, D Garcia-Garcia, P Clavero, JA Obeso, ...
Brain Imaging and Behavior 13, 180-188, 2019
282019
Investigating voice as a biomarker for leucine-rich repeat kinase 2-associated Parkinson’s disease
S Arora, NP Visanji, TA Mestre, A Tsanas, A AlDakheel, BS Connolly, ...
Journal of Parkinson's disease 8 (4), 503-510, 2018
262018
Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis
C Gasca-Salas, M Masellis, E Khoo, BB Shah, D Fisman, AE Lang, ...
PLoS One 11 (4), e0153852, 2016
262016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20